COM:MAGENTATX
Dianthus Therapeutics, Inc.
- Stock
Last Close
0.76
11/09 20:00
Market Cap
42.44M
Beta: -
Volume Today
375.91K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 15K - | |||||||
average payables | 917K - | 1.83M 99.51% | 3.15M 72.29% | 3.29M 4.25% | 3.40M 3.47% | 2.75M 19.21% | ||
average receivables | 3.13M - | |||||||
book value per share | 0.42 - | 2.34 456.53% | 7.92 238.37% | 3.81 51.84% | 3.28 14.10% | 3.14 4.09% | 1.78 43.21% | |
capex per share | -0.01 - | -0.10 1,482.01% | -0.42 307.87% | -0.08 80.18% | -0.01 88.98% | -0.02 152.58% | -0.01 77.01% | |
capex to depreciation | -23.17 - | -5.85 74.76% | -8.77 49.92% | -1.66 81.06% | -0.20 87.82% | -0.63 209.43% | -0.16 73.93% | |
capex to operating cash flow | 0.02 - | 0.10 363.95% | 0.18 85.44% | 0.05 70.74% | 0.01 88.34% | 0.02 239.84% | 0.00 77.96% | |
capex to revenue | ||||||||
cash per share | 0.21 - | 2.39 1,038.98% | 7.75 224.25% | 3.94 49.22% | 3.39 13.93% | 3.22 4.99% | 1.89 41.39% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | ||||||||
debt to assets | 0.20 - | |||||||
debt to equity | 0.28 - | |||||||
dividend yield | ||||||||
earnings yield | -0.03 - | -0.11 276.32% | -0.55 382.60% | -0.12 77.68% | -0.20 64.07% | -0.27 34.03% | -3.07 1,040.27% | |
enterprise value | 307.64M - | 260.76M 15.24% | 46.48M 82.18% | 496.07M 967.39% | 286.18M 42.31% | 111.77M 60.94% | -4.21M 103.77% | |
enterprise value over ebitda | -33.22 - | -7.43 77.64% | -0.78 89.56% | -5.98 671.42% | -3.64 39.18% | -1.50 58.85% | 0.05 103.56% | |
ev to operating cash flow | -47.12 - | -11.71 75.14% | -1.11 90.53% | -8.69 682.95% | -4.47 48.55% | -1.88 58.00% | 0.06 103.34% | |
ev to sales | ||||||||
free cash flow per share | -0.31 - | -1.14 266.86% | -2.69 136.84% | -1.63 39.69% | -1.47 9.75% | -1.11 24.57% | -1.14 2.61% | |
free cash flow yield | -0.02 - | -0.08 266.86% | -0.47 503.32% | -0.11 77.32% | -0.19 74.50% | -0.25 33.49% | -2.87 1,050.80% | |
graham net net | 0.32 - | 2.20 583.39% | 7.12 223.82% | 3.39 52.40% | 2.99 11.88% | 2.91 2.67% | 1.20 58.64% | |
graham number | 2.04 - | 9.32 357.64% | 23.61 153.19% | 12.62 46.53% | 10.78 14.63% | 9.18 14.77% | 6.98 24.01% | |
income quality | 0.69 - | 0.63 9.39% | 0.73 16.10% | 0.74 2.14% | 0.85 14.86% | 0.84 2.05% | 0.88 4.85% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -56.86 - | 18.22 - | ||||||
interest debt per share | 0.01 - | 0.43 - | ||||||
inventory turnover | ||||||||
invested capital | 0.28 - | |||||||
market cap | 312.16M - | 312.16M 0% | 104.82M 66.42% | 561.15M 435.34% | 344.33M 38.64% | 243.42M 29.31% | 23.45M 90.37% | |
net current asset value | 8.53M - | 48.36M 466.69% | 133.66M 176.37% | 129.52M 3.09% | 133.81M 3.31% | 159.66M 19.32% | 74.92M 53.08% | |
net debt to ebitda | 0.49 - | 1.46 200.42% | 0.97 33.53% | 0.78 19.40% | 0.74 5.79% | 1.76 138.54% | 0.35 80.13% | |
net income per share | -0.44 - | -1.65 276.32% | -3.13 89.45% | -1.86 40.63% | -1.58 15.15% | -1.19 24.27% | -1.21 1.67% | |
operating cash flow per share | -0.30 - | -1.04 240.99% | -2.28 119.95% | -1.54 32.27% | -1.46 5.51% | -1.08 25.68% | -1.13 4.30% | |
payables turnover | ||||||||
receivables turnover | ||||||||
research and ddevelopement to revenue | ||||||||
return on tangible assets | -0.83 - | -0.65 21.63% | -0.37 43.90% | -0.43 16.38% | -0.43 0.61% | -0.35 19.37% | -0.49 42.29% | |
revenue per share | ||||||||
roe | -1.04 - | -0.71 32.38% | -0.39 44.01% | -0.49 23.26% | -0.48 1.22% | -0.38 21.03% | -0.68 79.03% | |
roic | -1.02 - | -0.71 30.27% | -0.43 39.94% | -0.53 22.56% | -0.50 4.01% | -0.40 21.05% | -0.46 15.23% | |
sales general and administrative to revenue | ||||||||
shareholders equity per share | 0.42 - | 2.34 456.53% | 7.92 238.37% | 3.81 51.84% | 3.28 14.10% | 3.14 4.09% | 1.78 43.21% | |
stock based compensation to revenue | ||||||||
tangible asset value | 9.04M - | 50.32M 456.53% | 145.65M 189.44% | 141.19M 3.06% | 143.91M 1.92% | 172.67M 19.99% | 105.96M 38.64% | |
tangible book value per share | 0.42 - | 2.34 456.53% | 7.92 238.37% | 3.81 51.84% | 3.28 14.10% | 3.14 4.09% | 1.78 43.21% | |
working capital | 8.53M - | 48.36M 466.69% | 134.90M 178.95% | 135.73M 0.61% | 140.10M 3.22% | 166.06M 18.53% | 101.05M 39.15% |
All numbers in (except ratios and percentages)